Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

NCT07121972
unknown

ARTIFICIAL INTELLIGENCE IN REPRODUCTIVE MEDICINE

NCT05699850
unknownnot_applicable

China Lung Cancer Screening (CLUS) Study Version 2.0

NCT03975504

Clinical Trials (3)

Showing 3 of 3 trials
NCT07121972Not Applicable

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Recruiting
NCT05699850

ARTIFICIAL INTELLIGENCE IN REPRODUCTIVE MEDICINE

Unknown
NCT03975504Not Applicable

China Lung Cancer Screening (CLUS) Study Version 2.0

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3